BEAM
Beam Therapeutics Inc.
There isn't enough reported data to score BEAM yet.
HIMS
Hims & Hers Health, Inc.
There isn't enough reported data to score HIMS yet.
BEAM Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Under pressure | |
| Weak | |
| Unavailable |
BEAM's revenue is currently healthy, but its profitability and cash flow are under pressure. There isn't enough data to rate its balance sheet.
HIMS Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Weak | |
| Stable | |
| Strong |
HIMS's revenue and balance sheet are currently strong, and its cash flow is stable, but its profitability is weak.
BEAM PE Valuation
BEAM has no meaningful PE right now: it lost money over the past year.
HIMS PE Valuation
HIMS has no meaningful PE right now: it lost money over the past year.
BEAM Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong decline | |
| -- | |
| Limited | |
| Low |
Analysts expect BEAM's losses to grow, with revenue declining. However, they disagree widely on these estimates.
HIMS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Turning to a loss | |
| Strong growth | |
| Stable | |
| Limited | |
| Low |
Analysts expect HIMS's revenue to grow, but its earnings to decline. However, they disagree widely on these estimates.
BEAM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.84 | +$3.59 |
| Q2 2026 | -$0.66 | +$3.84 |
| Q1 2026 | -$0.48 | +$4.13 |
| Q4 2025 | -$0.81 | +$3.77 |
| Q3 2025 | -$4.43 | -$2.85 |
| Q2 2025 | -$4.50 | -$2.87 |
| Q1 2025 | -$4.61 | -$3.01 |
| Q4 2024 | -$4.58 | -$2.86 |
BEAM is still losing money, but far less than before: $0.84 per share over the past year, against $7.05 at its worst in mid-2021.
HIMS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.83 | -257% |
| Q2 2026 | -$0.63 | -180% |
| Q1 2026 | -$0.09 | -113% |
| Q4 2025 | $0.51 | -3.8% |
| Q3 2025 | $0.53 | +20% |
| Q2 2025 | $0.79 | +888% |
| Q1 2025 | $0.68 | +$0.69 |
| Q4 2024 | $0.53 | +$0.64 |
HIMS has swung to a loss: it lost $0.83 per share over the past year, after a profit the year before.
BEAM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $307K | -97% |
| Q2 2026 | $490K | -94% |
| Q1 2026 | $31.7M | +325% |
| Q4 2025 | $114.1M | +280% |
| Q3 2025 | $9.7M | -32% |
| Q2 2025 | $8.5M | -28% |
| Q1 2025 | $7.5M | +0.8% |
| Q4 2024 | $30.1M | -90% |
BEAM's revenue is growing: $307,000 last quarter, down 97% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -46033% | -44726 points |
| Q2 2026 | -25827% | -24408 points |
| Q1 2026 | -338% | +1259 points |
| Q4 2025 | -15% | +317 points |
| Q3 2025 | -1308% | -561 points |
| Q2 2025 | -1419% | -528 points |
| Q1 2025 | -1597% | -192 points |
| Q4 2024 | -333% | -375 points |
BEAM's operating margin was −46033% last quarter, down 44726 points from the same quarter a year ago.
HIMS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $890.4M | +49% |
| Q2 2026 | $753.2M | +38% |
| Q1 2026 | $608.1M | +3.8% |
| Q4 2025 | $617.8M | +28% |
| Q3 2025 | $599M | +49% |
| Q2 2025 | $544.8M | +73% |
| Q1 2025 | $586M | +111% |
| Q4 2024 | $481.1M | +95% |
HIMS has the edge over BEAM on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -7.4% | -9.4 points |
| Q2 2026 | -13% | -18 points |
| Q1 2026 | -13% | -23 points |
| Q4 2025 | 1.5% | -2.4 points |
| Q3 2025 | 2% | -3.6 points |
| Q2 2025 | 4.9% | +1.4 points |
| Q1 2025 | 9.9% | +6.3 points |
| Q4 2024 | 3.9% | +4 points |
HIMS has the edge over BEAM on profitability, with a higher operating margin.
BEAM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$112M | -$25.5M |
| Q2 2026 | -$68.5M | +$11.1M |
| Q1 2026 | -$130.7M | -$23.8M |
| Q4 2025 | -$87M | -$7.7M |
| Q3 2025 | -$86.5M | +$3.2M |
| Q2 2025 | -$79.6M | +$5.4M |
| Q1 2025 | -$106.9M | -$4.8M |
| Q4 2024 | -$79.3M | -160% |
BEAM has burned cash in almost every quarter: −$398M over the past year, against −$352M the year before.
HIMS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $26M | -67% |
| Q2 2026 | -$68.2M | +$1.3M |
| Q1 2026 | $53.1M | +5.9% |
| Q3 2025 | $79.3M | -7% |
| Q2 2025 | -$69.5M | -230% |
| Q1 2025 | $50.1M | +94% |
| Q3 2024 | $85.3M | +238% |
| Q2 2024 | $53.6M | +219% |
HIMS has the edge over BEAM on cash generation, producing positive trailing cash flow while its opponent burns cash.
BEAM Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.4% | +372K shares |
| 1 year | +2.1% | +2.1M shares |
| 3 years | +32% | +25.7M shares |
| 5 years | +58% | +38.3M shares |
| Available history | +241% | +74M shares |
BEAM has 105M diluted shares, up 2.1% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2019 | — |
HIMS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.9% | +2.1M shares |
| 1 year | -6% | -14.9M shares |
| 3 years | +11% | +23.7M shares |
| 5 years | +17% | +33.8M shares |
HIMS has the edge over BEAM on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2025 | $80.5M |
| Q3 2025 | $9.5M |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | $5M |
| Q3 2024 | $30M |
| Q2 2024 | $19.9M |
| Q1 2024 | $28.1M |
BEAM Net Leverage
BEAM's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
HIMS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | -5.9x | Net Cash |
| Q4 2025 | -1.4x | Net Cash |
| Q3 2025 | -2.2x | Net Cash |
| Q2 2025 | -7.3x | Net Cash |
| Q1 2025 | -2.1x | Net Cash |
| Q4 2024 | -2.8x | Net Cash |
| Q3 2024 | -2.9x | Net Cash |
| Q2 2024 | -5.5x | Net Cash |
HIMS has more cash than debt.
BEAM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 44.3 | Neutral |
| Stochastic | 36.5 | Neutral |
BEAM's weekly RSI is 44 (neutral) and its Stochastic is 37 (neutral).
HIMS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 36.0 | Neutral |
| Stochastic | 23.0 | Neutral |
HIMS's weekly RSI is 36 (neutral) and its Stochastic is 23 (neutral).
BEAM PE vs Healthcare Sector
BEAM has no meaningful PE right now: it lost money over the past year.
HIMS PE vs Healthcare Sector
| Metric | HIMS | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
HIMS has no meaningful PE right now: it lost money over the past year.
BEAM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $25.0 | 3.7% below |
| 20 week MA | $26.9 | 11% below |
| 50 week MA | $27.8 | 14% below |
| 100 week MA | $25.0 | 3.7% below |
| 200 week MA | $26.7 | 10% below |
BEAM is in a downtrend: it's below all five of its weekly moving averages, and 10% below its 200-week average.
HIMS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $27.3 | 28% below |
| 20 week MA | $29.2 | 32% below |
| 50 week MA | $27.7 | 29% below |
| 100 week MA | $35.9 | 45% below |
| 200 week MA | $24.4 | 19% below |
HIMS is in a downtrend: it's below all five of its weekly moving averages, and 19% below its 200-week average.
BEAM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $20.6 | $87.8 | +326% |
| 2021 | $87.8 | $86.5 | -1.5% |
| 2022 | $86.5 | $40.4 | -53% |
| 2023 | $40.4 | $27.2 | -33% |
| 2024 | $27.2 | $26.6 | -2.3% |
| 2025 | $26.6 | $28.0 | +5.2% |
| 2026 YTD | $28.0 | $24.0 | -14% |
BEAM has the edge over HIMS on returns for 2026, with the stronger performance.
HIMS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.89 | $15.0 | +51% |
| 2021 | $15.0 | $6.65 | -56% |
| 2022 | $6.65 | $6.43 | -3.3% |
| 2023 | $6.43 | $8.90 | +38% |
| 2024 | $8.90 | $26.6 | +198% |
| 2025 | $26.6 | $34.3 | +29% |
| 2026 YTD | $34.3 | $19.7 | -42% |
HIMS's yearly returns have swung widely, from +198% in 2024 to −56% in 2021. It's down 42% so far in 2026.